Sepsis & infection

Effectiveness of toothbrushing as a replacement for chlorhexidine in oral care, combined with head elevation for the prevention of ventilator-associated pneumonia in intensive care units: interrupted time-series analysis

Crit CarePublished Quasi-experimental study with interrupted time-series analysis

Authors' conclusion

Implementation of toothbrushing-based oral care combined with reinforced HOBE was followed by lower VAP incidence in the primary ITS analysis

Study context

Population
Adult ICU patients in eight intensive care units (ICUs) of a 2,734-bed tertiary care hospital in Seoul, South Korea8 adult ICUs
Comparison
Pre-intervention vs Post-intervention
Outcome
Monthly VAP incidence rate
Follow-up
August 2022 through November 2024
Methodological detailsbefore-after, 8 adult ICUs, tertiary care hospital
  • Before-after
  • 8 adult ICUs
  • Tertiary care hospital

Main finding

As reported in the abstract

Monthly VAP incidence (ITS analysis)

Pre-intervention ventilator-associated pneumonia (VAP) rate: 66 cases during 16,849 device-days

3.9 per 1,000 device-days

Post-intervention VAP rate: 78 cases during 32,185 device-days

2.4 per 1,000 device-days

Further findings

Head-of-bed elevation (HOBE) adherence

HOBE adherence increased significantly from 84 to 95% after the intervention, P < 0.001

VAP incidence, sensitivity analyses

Alternative transition windows and negative binomial models: directionally consistent post-intervention declines
Fully covariate-adjusted interrupted time-series (ITS) model: estimates attenuated and not statistically significant

Original publication

Effectiveness of toothbrushing as a replacement for chlorhexidine in oral care, combined with head elevation for the prevention of ventilator-associated pneumonia in intensive care units: interrupted time-series analysis. Crit Care. Published 6 March 2026. doi:10.1186/s13054-026-05936-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.